Included among these are Sirt1, Hey2, Ncoa4, and Foxa1, all of which have been implicated in the progression of luminal breast cancer and ER-α-dependent signaling, as well as ER-α (that is, Esr 1) (Additional file 2). Here, NCOA4 is linked to breast carcinoma.